butalbital, acetaminophen, caffeine and codeine phosphate
Generic: butalbital, acetaminophen, caffeine and codeine phosphate
Labeler: breckenridge pharmaceutical, inc.Drug Facts
Product Profile
Brand Name
butalbital, acetaminophen, caffeine and codeine phosphate
Generic Name
butalbital, acetaminophen, caffeine and codeine phosphate
Labeler
breckenridge pharmaceutical, inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
acetaminophen 325 mg/1, butalbital 50 mg/1, caffeine 40 mg/1, codeine phosphate 30 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
51991-073
Product ID
51991-073_2e57797a-2cd4-4f32-ae8b-2db74f699b61
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA076560
DEA Schedule
ciii
Listing Expiration
2026-12-31
Marketing Start
2004-07-01
Pharmacologic Class
Established (EPC)
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
51991073
Hyphenated Format
51991-073
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
butalbital, acetaminophen, caffeine and codeine phosphate (source: ndc)
Generic Name
butalbital, acetaminophen, caffeine and codeine phosphate (source: ndc)
Application Number
ANDA076560 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 325 mg/1
- 50 mg/1
- 40 mg/1
- 30 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-073-01)
Packages (1)
Ingredients (4)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2e57797a-2cd4-4f32-ae8b-2db74f699b61", "openfda": {"nui": ["N0000175693", "M0002177", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "KHS0AZ4JVK", "3G6A5W338E", "GSL05Y1MN6"], "rxcui": ["993943"], "spl_set_id": ["d74db417-d2de-495b-bb75-46a83745603d"], "pharm_class_cs": ["Barbiturates [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Barbiturate [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE, PLASTIC (51991-073-01)", "package_ndc": "51991-073-01", "marketing_start_date": "20040701"}], "brand_name": "Butalbital, Acetaminophen, Caffeine and Codeine Phosphate", "product_id": "51991-073_2e57797a-2cd4-4f32-ae8b-2db74f699b61", "dosage_form": "CAPSULE", "pharm_class": ["Barbiturate [EPC]", "Barbiturates [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Full Opioid Agonists [MoA]", "Methylxanthine [EPC]", "Opioid Agonist [EPC]", "Xanthines [CS]"], "product_ndc": "51991-073", "dea_schedule": "CIII", "generic_name": "Butalbital, Acetaminophen, Caffeine and Codeine Phosphate", "labeler_name": "Breckenridge Pharmaceutical, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Butalbital, Acetaminophen, Caffeine and Codeine Phosphate", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "325 mg/1"}, {"name": "BUTALBITAL", "strength": "50 mg/1"}, {"name": "CAFFEINE", "strength": "40 mg/1"}, {"name": "CODEINE PHOSPHATE", "strength": "30 mg/1"}], "application_number": "ANDA076560", "marketing_category": "ANDA", "marketing_start_date": "20040701", "listing_expiration_date": "20261231"}